Avalo Therapeutics Inc. (AVTX)
undefined
undefined%
At close: undefined
9.23
0.05%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Revenue 1.92M 18.05M 5.40M 6.70M 6.75M 18.33M 27.81M 1.15M - - - 82.76K
Cost of Revenue 1.28M 3.43M 1.49M 300.00K 11.63M 7.48M 635.65K 8.24M 23.51K 9.50M - 8.48M
Gross Profit 640.00K 14.62M 3.91M 6.40M -4.88M 10.85M 27.18M -7.09M -23.51K -9.50M - -8.39M
Operating Income -23.44M -37.44M -82.13M -26.95M -17.39M -39.31M 13.89M -16.08M -11.01M -17.12M -12.93M -10.49M
Interest Income - 4.17M 2.39M 49.00K 121.33K - - - - - - 1.35K
Pretax Income -31.53M -41.63M -84.55M -67.18M -15.99M -40.09M 13.84M -16.47M -10.49M -16.06M -13.05M -10.49M
Net Income -31.54M -41.66M -84.35M -64.38M -16.27M -40.05M 11.87M -16.47M -10.49M -16.06M -13.05M -10.49M
Selling & General & Admin 10.30M 20.71M 24.66M 19.76M 11.61M 19.20M 8.91M 7.08M 4.42M 4.88M 4.02M 2.10M
Research & Development 13.78M 31.31M 59.84M 32.19M 11.76M 5.79M 4.37M 10.15M 6.59M 12.24M 8.91M 8.48M
Other Expenses -23.44M 38.00K 1.55M 1.74M 1.34M 13.66K - - - - - -
Operating Expenses 640.00K 52.06M 86.04M 53.69M 24.71M 29.52M 13.29M 17.23M 11.01M 17.12M 12.93M 2.10M
Interest Expense 3.42M 4.17M 2.39M - - - - - 793.21K 1.21M 10.55K -
Selling & Marketing Expenses 33.00K 76.00K 2.83M 2.34M 1.48M 8.52M 973.35K - - - - -
Cost & Expenses 25.37M 55.49M 87.53M 53.99M 24.14M 37.00M 13.92M 17.23M 11.01M 17.12M 12.93M 10.57M
Income Tax 14.00K 28.00K -196.00K -2.79M 280.00K -33.91K 1.97M 364.14K -543.51K -1.06M 110.56K -
Shares Outstanding (Basic) 277.73K 39.20K 36.19K 25.51K 19.85K 12.07K 6.39K 3.07K 772.92 - - 52.51K
Shares Outstanding (Diluted) 277.73K 39.20K 36.19K 25.51K 19.85K 12.07K 6.51K 3.07K 772.92 - - 52.51K
EPS (Basic) -113.58 -1.06K -2.33K -2.52K -819.74 -3.32K 1.21K -5.37K -13.57K - - -199.77
EPS (Diluted) -113.58 -1.06K -2.33K -2.52K -819.74 -3.32K 1.21K -5.37K -13.57K - - -199.77
EBITDA -27.95M -37.29M -80.50M -45.45M -17.36M -13.07M 14.35M -16.05M -10.46M -17.09M -12.91M -10.48M
Depreciation & Amortization 158.00K 166.00K 1.66M 1.84M 1.46M 1.85M 425.48K 26.86K 23.51K 28.94K 20.03K 15.00K